News
![FDA building](https://pharmaphorum.com/wp-content/uploads/2017/05/FDA-building-image.jpg)
Luye claims its first FDA approval, for bi-weekly schizophre...
China's Luye Pharma has claimed its first FDA approval, getting a green light for Rykindo, an injectable formulation of the antipsychotic risperidone given every two weeks.